Graves' disease (GD) is an autoimmune disorder characterized by hyperthyroidism which is mediated by autoantibodies to the thyrotropin receptor (TSHr). Until now, it has not been possible to develop an animal model for GD due to the unavailability of purified TSHr protein. However, recently we expressed the extracellular domain of human TSHr protein (ETSHr) using a baculovirus expression system. The protein was purified to homogeneity and was shown to bind specifically both TSH and antibodies to TSHr. We used this protein to generate anti-ETSHr antibodies that can bind to native TSHr and block thyrotropin (TSH) binding. As a result of successful protein expression, we will now pursue our long-term objective, which is to establish an animal model and understand the pathogenic mechanics involved in the GD. In the present study we propose to use the recombinant ETSHr protein to induce experimental autoimmune Graves' disease (EAGD) in mice. Initial studies will be aimed at defining optimum conditions, such as age, sex, and genetic background of mice, and dose and route of inoculation of the antigen. Anti-TSHr antibody production will be monitored using an ELISA. Sera from seropositive animals will be tested for the presence of antibodies that can block TSH binding to TSHr (TB11) using a radioreceptor assay. Perturbation of thyroid function in TB11 positive animals will be detected by testing sera for both TSH and thyroxine levels using radioimmunoassays. Thyroid glands from mice with EAGD will be used for evaluating the pathology and for phenotyping infiltrating cells. Systematic characterization of T cell responses will be carried out using in vitro cell proliferation assays, by adoptive transfer experiments and by selective depletion of various subsets of T cells and B cells in vitro and in vivo. Finally, using a panel of overlapping synthetic peptides, that span the entire ETSHr, and peptide fragments of ETSHr we will attempt to map some of the B cell and T cell epitopes that are critical for EAGD. Together, these studies should result in the establishment of a mouse model for GD, that would allow systematic studies to understand regulation of immune response to TSHr. Moreover, these studies might lead to the identification of some of the T cell and B cell epitopes with potential implications for developing TSHr- specific immunotherapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK047417-01A2
Application #
2146995
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1995-06-01
Project End
1998-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Martinez, Osvaldo; Gangi, Eryn; Mordi, David et al. (2007) Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses. Endocrinology 148:752-61
Singh, Surya P; McDonald, David; Hope, Thomas J et al. (2004) Upon thyrotropin binding the thyrotropin receptor is internalized and localized to endosome. Endocrinology 145:1003-10
Gangi, Eryn; Kapatral, Vinayak; El-Azami El-Idrissi, Mohammed et al. (2004) Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor. Autoimmunity 37:515-20
Vasu, Chenthamarakshan; Wang, Amy; Gorla, Seema R et al. (2003) CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties. Int Immunol 15:167-75
Vasu, Chenthamarakshan; Holterman, Mark J; Prabhakar, Bellur S (2003) Modulation of dendritic cell function and cytokine production to prevent thyroid autoimmunity. Autoimmunity 36:389-96
Vasu, Chenthamarakshan; Dogan, Rukiye-Nazan E; Holterman, Mark J et al. (2003) Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol 170:5511-22
Prasad, Kanteti V; Prabhakar, Bellur S (2003) Apoptosis and autoimmune disorders. Autoimmunity 36:323-30
Dogan, Rukiye-Nazan E; Vasu, Chenthamarakshan; Holterman, Mark J et al. (2003) Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 170:2195-204
Cundiff, J G; Kaithamana, S; Seetharamaiah, G S et al. (2001) Studies using recombinant fragments of human TSH receptor reveal apparent diversity in the binding specificities of antibodies that block TSH binding to its receptor or stimulate thyroid hormone production. J Clin Endocrinol Metab 86:4254-60
Rao, S; Vasu, C; Martinez, O et al. (2001) Targeted delivery of anti-CTLA-4 antibody downregulates T cell function in vitro and in vivo. Clin Immunol 101:136-45

Showing the most recent 10 out of 24 publications